4//SEC Filing
Tursi James Patrick 4
Accession 0001104659-18-033905
CIK 0001660719other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 7:49 PM ET
Size
17.4 KB
Accession
0001104659-18-033905
Insider Transaction Report
Form 4
Tursi James Patrick
Chief Medical Officer
Transactions
- Sale
Common Shares, without par value
2018-05-14$0.52/sh−9,348$4,882→ 242,052 total
Footnotes (2)
- [F1]This represents shares sold by the issuer on behalf of the reporting person pursuant to an instruction made in accordance with Rule 10b5-1 for payment of withholding tax liability incurred upon the vesting of 27,730 restricted stock units, which were previously granted on May 11, 2017 and which vested on May 11, 2018.
- [F2]This transaction was executed in multiple trades at prices ranging from $0.5206 to $0.5269. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Aralez Pharmaceuticals Inc.
CIK 0001660719
Entity typeother
Related Parties
1- filerCIK 0001527710
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 7:49 PM ET
- Size
- 17.4 KB